These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2697905)

  • 1. Methods of evaluation of psychoactive drugs.
    Bech P
    Recenti Prog Med; 1989 Dec; 80(12):706-11. PubMed ID: 2697905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of generalized anxiety: new pharmacologic approaches].
    Boulenger JP
    Encephale; 1995; 21(6):459-66. PubMed ID: 8674471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The AMDP scales in a phase II evaluation of psychotropic drugs].
    Digonnet C; Boyer P; Puech AJ; von Frenckell R; Weil JS
    Acta Psychiatr Belg; 1987; 87(2):245-52. PubMed ID: 3618275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Citalopram dose-response revisited using an alternative psychometric approach to evaluate clinical effects of four fixed citalopram doses compared to placebo in patients with major depression.
    Bech P; Tanghøj P; Andersen HF; Overø K
    Psychopharmacology (Berl); 2002 Aug; 163(1):20-5. PubMed ID: 12185396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Major or minor tranquilizers for relief of common symptoms of psychoneurosis?
    Krivda JF
    J Psychiatr Nurs Ment Health Serv; 1974; 12(4):28-33. PubMed ID: 4368887
    [No Abstract]   [Full Text] [Related]  

  • 7. [New anxiolytic drugs: methodological issues].
    Ginestet D; Corruble E
    Encephale; 1993; 19(6):627-37. PubMed ID: 12404782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acting out and psychoactive substances: alcohol, drugs, illicit substances].
    Gillet C; Polard E; Mauduit N; Allain H
    Encephale; 2001; 27(4):351-9. PubMed ID: 11686057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Review of psychopharmacological treatments in adolescents and adults with autistic disorders].
    Baghdadli A; Gonnier V; Aussilloux C
    Encephale; 2002; 28(3 Pt 1):248-54. PubMed ID: 12091786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The psychotropic effect of the Pyrovalerone (F-1983), placebo, the milieu therapy and mental condition of the patients in forensic psychiatry].
    Söderholm S; Viukari NM; Rimón R
    Nervenarzt; 1976 Feb; 47(2):88-93. PubMed ID: 768789
    [No Abstract]   [Full Text] [Related]  

  • 11. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
    Kane JM; Leucht S; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applied psychometrics in clinical psychiatry: the pharmacopsychometric triangle.
    Bech P
    Acta Psychiatr Scand; 2009 Nov; 120(5):400-9. PubMed ID: 19807722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rating scales for states for anxiety, depression, mania and schizophrenia. A multiaxial approach.
    Kastrup M; Bech P; Rafaelsen OJ
    Acta Psychiatr Belg; 1986; 86(5):575-81. PubMed ID: 2881427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early phase-II semi double-blind study of the new alkaline propanolamine derivative enciprazine (short communication).
    Linden M; Helmchen H; Müller-Oerlinghausen B
    Arzneimittelforschung; 1988 Jun; 38(6):814-6. PubMed ID: 3178922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selected methodological issues in the evaluation of psychotropic medications in neurotic outpatients.
    Downing RW
    Psychopharmacol Bull; 1975 Jul; 11(3):19-21. PubMed ID: 1153646
    [No Abstract]   [Full Text] [Related]  

  • 16. Reliability and validity of the Korean version of UKU-SERS-Pat in patients with bipolar disorder.
    Kim JH; Choi SW; Joe SH; Ha TH; Yoo HJ; Choi JE; Cha B; Ha K
    Nord J Psychiatry; 2008; 62(6):496-502. PubMed ID: 18841509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [General methodological problems of psychotropic drug trials (author's transl)].
    Heimann H
    Pharmakopsychiatr Neuropsychopharmakol; 1977 May; 10(3):119-29. PubMed ID: 360236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current status of the clinical evaluation of psychotropic drugs].
    Moizeszowicz J
    Acta Psiquiatr Psicol Am Lat; 1975 Mar; 21(1):41-51. PubMed ID: 1163268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Placebo response and antidepressant clinical trial outcome.
    Khan A; Detke M; Khan SR; Mallinckrodt C
    J Nerv Ment Dis; 2003 Apr; 191(4):211-8. PubMed ID: 12695731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tricyclic antidepressants dosage and depressed elderly inpatients: a retrospective pharmaco-epidemiologic study].
    Ballon N; Siobud-Dorocant E; Even C; Slama F; Dardennes R
    Encephale; 2001; 27(4):373-6. PubMed ID: 11686060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.